Usana Health Sciences Q3 EPS $0.56 Beats $0.48 Estimate, Sales $200.22M Miss $205.77M Estimate
Portfolio Pulse from Benzinga Newsdesk
Usana Health Sciences reported Q3 earnings per share of $0.56, surpassing the analyst estimate of $0.48, but sales of $200.22 million fell short of the $205.77 million estimate. Both earnings and sales decreased compared to the same period last year.
October 22, 2024 | 8:14 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Usana Health Sciences reported Q3 EPS of $0.56, beating estimates, but sales of $200.22M missed expectations. Both figures declined from last year.
The earnings per share beat expectations, which is positive, but the sales miss and year-over-year declines in both earnings and sales could offset this positive news. The mixed results may lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100